{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:03:38Z","timestamp":1789401818094,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejpn.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T14:02:03Z","timestamp":1373292123000},"page":"631-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?"],"prefix":"10.1016","volume":"17","author":[{"given":"Gert","family":"Wiegand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor W.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ostertag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Stephani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Neal","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2013.06.002_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","article-title":"Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations","volume":"16","author":"Curatolo","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.ejpn.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/era.11.93","article-title":"Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis","volume":"11","author":"Franz","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejpn.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant-cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11207730-000000000-00000","article-title":"Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"14","author":"Curran","year":"2012","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ejpn.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpn.2011.09.006","article-title":"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in patient with tuberous sclerosis complex","volume":"16","author":"Perek-Polnik","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2013.06.002_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejpn.2013.06.002_bib9","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.ejpn.2013.06.002_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.0b013e318247ca8d","article-title":"Everolimus alters white matter diffusion in tuberous sclerosis complex","volume":"78","author":"Tillema","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejpn.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11910-012-0276-5","article-title":"Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy","volume":"12","author":"Ryther","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ejpn.2013.06.002_bib12","series-title":"Jasper's basic mechanisms of the epilepsies","article-title":"Crino PB mTOR and epileptogenesis in developmental brain malformations","author":"Wong","year":"2012"},{"issue":"6","key":"10.1016\/j.ejpn.2013.06.002_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2013.06.002_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.ejpn.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2013.06.002_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10309-009-0086-1","article-title":"E-Health in der p\u00e4diatrischen Epileptologie","volume":"23","author":"Baudhuin","year":"2010","journal-title":"Z f\u00fcr Epileptologie"},{"key":"10.1016\/j.ejpn.2013.06.002_bib17","first-page":"2","article-title":"Der elektronische Behandlungskalender (Epivista)","volume":"15","author":"Rabending","year":"2002","journal-title":"Z f\u00fcr Epileptologie"},{"key":"10.1016\/j.ejpn.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejpn.2012.10.006","article-title":"Myoclonic astatic epilepsy (Doose syndrome) \u2013 a lamotrigine responsive epilepsy?","volume":"17","author":"Doege","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.06.002_bib19","unstructured":"Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0. (http:\/\/ctep.cancer.gov)."},{"key":"10.1016\/j.ejpn.2013.06.002_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/biomet\/42.1-2.80","article-title":"Some quick sign tests for trend in location and dispersion","volume":"42","author":"Cox","year":"1955","journal-title":"Biometrika"},{"key":"10.1016\/j.ejpn.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2307\/2532086","article-title":"Some covariance models for longitudinal count data with overdispersion","volume":"46","author":"Thall","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.ejpn.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/08830738050200040901","article-title":"Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment","volume":"20","author":"Curatolo","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2013.06.002_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"9861","key":"10.1016\/j.ejpn.2013.06.002_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejpn.2013.06.002_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.inf.0000195623.57945.87","article-title":"Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology","volume":"25","author":"Vernacchio","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ejpn.2013.06.002_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2013.06.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2013.03.002","article-title":"Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","author":"Kotulska","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"21","key":"10.1016\/j.ejpn.2013.06.002_bib28","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.ejpn.2013.06.002_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2013.06.002_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential anti-epileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ejpn.2013.06.002_bib31","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejpn.2013.06.002_bib32","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1528-1167.2011.02981.x","article-title":"The ketogenic diet inhibits the mammalian target of apamycin (mTOR) pathway","volume":"52","author":"McDaniel","year":"2011","journal-title":"Epilepsia"},{"issue":"15\u201316","key":"10.1016\/j.ejpn.2013.06.002_bib33","first-page":"861","article-title":"Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries","volume":"17","author":"Don","year":"2012","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.ejpn.2013.06.002_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"46","key":"10.1016\/j.ejpn.2013.06.002_bib35","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.C500363200","article-title":"Glutamatergic regulation of the p70S6 kinase in primary mouse neurons","volume":"280","author":"Lenz","year":"2005","journal-title":"J Biol Chem"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T18:53:28Z","timestamp":1539543208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379813001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1090379813001025"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.06.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}